• The overall aim of the project “RespiraTox” is to develop a QSAR model and user-friendly tool that reliably predicts human respiratory irritancy of single compounds and mixtures. Dr. Sylvia Escher and her team from Fraunhofer ITEM are contributing a profound knowledge in toxicological data, while Dr. Andreas Karwath and his team from the University of Birmingham are responsible for the modeling and machine learning part.

    more info
  • In an interview, Dr. Tanja Hansen explained how airborne pollutants can be detected, identified, and assessed with animal-free methods or only a minimum of animal experiments.

    more info
  • Having participated in the official taster day already during the past years, Fraunhofer ITEM this year again received 23 “tasters” who took the opportunity to get insights into the working environment at Fraunhofer ITEM.

    more info
  • In the publicly funded project TransPlaMed (NBank), the Institute for Microtechnology (IMT) of Technische Universität Braunschweig, the Lower Saxony Center for Biomedical Engineering, Implant Research and Development (NIFE), the University of Applied Sciences and Arts in Göttingen (HAWK), the Fraunhofer Institute for Surface Engineering and Thin Films IST, and the Fraunhofer Institute for Toxicology and Experimental Medicine ITEM are collaborating to develop a translational manufacturing platform for innovative medical devices.

    more info
  • The new Medical Device Regulation (MDR) that became effective in summer 2017 poses a challenge in particular for small and medium-sized biomedical engineering enterprises, since it requires conformity evaluation not only of future innovations, but also reassessment of existing products. Initiated by the High Performance Center Translational Biomedical Engineering, representatives from industry and academia discussed the issue of medical device safety during the meeting of the expert panel on functional interfaces of the VDE/VDI Society Microelectronics, Microsystems and Precision Engineering in Frankfurt (Germany) on January 22, 2018.

    more info
  • Fraunhofer ITEM tested a COPD drug from Novartis Pharma GmbH for its potential to improve heart function / 2018

    Innovative clinical study: a successful step in COPD research

    News / 22.2.2018

    In a clinical trial performed at the Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, administration of a combination drug from Novartis (incacaterol/glycopyrronium) was shown to improve not only lung function in COPD patients, but to have a significantly positive effect on their heart function as well. The results of this study have now been published in the renowned journal “The Lancet Respiratory Medicine”.

    more info
  • CRACK IT Challenge competition 2017 / 2018

    Great success for Fraunhofer ITEM scientists

    News / 21.2.2018

    Two Fraunhofer ITEM scientists have been awarded funding for their projects in the 2017 CRACK IT Challenge competition. The CRACK IT Challenge is the NC3Rs’ response to the changing environment in the biosciences. The NC3Rs is a UK-based scientific organization dedicated to replacing, refining and reducing the use of animals in research and testing.

    more info
  • Prof. Schlüter, member of the board of trustees of the Fraunhofer ITEM, passed away / 2018

    Obituary: Professor Gerhard Schlüter

    News / 12.2.2018

    Professor Gerhard Schlüter, 78, passed away on January 30, 2018. His death means that we have lost not only a dedicated toxicologist but also a close companion.

    more info